These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27579959)

  • 1. Developing Guidelines for the Reversal of Anticoagulant and Antithrombotic Agents in the Setting of Intracranial Hemorrhage.
    Christensen MA; Cooper CM
    J Neurosci Nurs; 2016 Oct; 48(5):256-9. PubMed ID: 27579959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.
    Frontera JA; Lewin JJ; Rabinstein AA; Aisiku IP; Alexandrov AW; Cook AM; del Zoppo GJ; Kumar MA; Peerschke EI; Stiefel MF; Teitelbaum JS; Wartenberg KE; Zerfoss CL
    Neurocrit Care; 2016 Feb; 24(1):6-46. PubMed ID: 26714677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-injury antithrombotic agents predict intracranial hemorrhagic progression, but not worse clinical outcome in severe traumatic brain injury.
    Svedung Wettervik T; Lenell S; Enblad P; Lewén A
    Acta Neurochir (Wien); 2021 May; 163(5):1403-1413. PubMed ID: 33770261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Nielsen PB; Larsen TB; Skjøth F; Gorst-Rasmussen A; Rasmussen LH; Lip GY
    Circulation; 2015 Aug; 132(6):517-25. PubMed ID: 26059010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation.
    Pennlert J; Asplund K; Carlberg B; Wiklund PG; Wisten A; Åsberg S; Eriksson M
    Stroke; 2015 Aug; 46(8):2094-9. PubMed ID: 26159794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis.
    Eckman MH; Rosand J; Knudsen KA; Singer DE; Greenberg SM
    Stroke; 2003 Jul; 34(7):1710-6. PubMed ID: 12805495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intracranial hemorrhages: epidemiology and implication of antithrombotic therapy].
    Varvat J; Epinat M; Nuti C; Antoine JC; Mismetti P; Garnier P
    Therapie; 2013; 68(3):143-7. PubMed ID: 23886458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs.
    Galliazzo S; Bianchi MD; Virano A; Trucchi A; Donadini MP; Dentali F; Bertù L; Grandi AM; Ageno W
    Thromb Res; 2019 Feb; 174():113-120. PubMed ID: 30593997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage.
    Chao TF; Liu CJ; Liao JN; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chen TJ; Lip GY; Chen SA
    Circulation; 2016 Apr; 133(16):1540-7. PubMed ID: 26969761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
    Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
    Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage: a clinical review.
    Campbell PG; Sen A; Yadla S; Jabbour P; Jallo J
    World Neurosurg; 2010; 74(2-3):279-85. PubMed ID: 21492561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke/thromboembolism and intracranial hemorrhage in a real-world atrial fibrillation population: the Complications of Atrial Fibrillation in the Bologna Area (CAFBO) study.
    Palareti G; Salomone L; Cavazza M; Guidi M; Muscari A; Boriani G; Di Micoli A; Guizzardi G; Procaccianti G; Guidetti A; Binetti N; Malservisi S; Masina M; Viola A; Bua V; Ongari M; Diaspri G; Lip GYH
    Chest; 2014 Oct; 146(4):1073-1080. PubMed ID: 24810397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
    Mooe T
    Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antithrombotic treatment of atrial fibrillation].
    Connelly SJ; Turpie AG
    Can J Cardiol; 1996 Feb; 12 Suppl A():14A-18A. PubMed ID: 8673946
    [No Abstract]   [Full Text] [Related]  

  • 16. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
    Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
    J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 19. Reversal and Resumption of Antithrombotic Therapy in LVAD-Associated Intracranial Hemorrhage.
    Cho SM; Moazami N; Katz S; Starling R; Frontera JA
    Ann Thorac Surg; 2019 Jul; 108(1):52-58. PubMed ID: 30763560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong.
    Siu CW; Lip GY; Lam KF; Tse HF
    Heart Rhythm; 2014 Aug; 11(8):1401-8. PubMed ID: 24747420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.